Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor?
Authors:
- 2 August 2014
- journal article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 141 (1) , 55-60
Abstract
Non-adherence to anti-hormonal therapy is a major problem in gynecologic oncology. Reasons reported are side effects and lack of support. The aim of our study was an analysis of influence of experiences of patients with endocrine therapy and communication and information on this topic and their influence on adherence. We developed a structured questionnaire which was tested in a pilot version and then programmed as online questionnaire and presented to patient members of self-help and breast cancer organizations. Patients only had received scarce information on endocrine therapy. Only 12.8 % stated that their questions were answered in detail, 43.2 % got no answers or only non-detailed answers. 76 % had side effects limiting functions of daily life. 60 % of physicians did not react on these side effects. There is a significant correlation between number and intensity of side effects and non-adherence or disruption of therapy (p = 0.029 and p < 0.01, respectively). Women who reported having received detailed answers to their questions also reported better adherence (p = 0.014). In order to improve adherence, detailed information on side effects and answers in case of symptoms are most important. Physicians should not rely on presenting written information but should mainly engage in direct communication.Keywords
This publication has 20 references indexed in Scilit:
- The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancerAnnals of Oncology, 2013
- Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based studyBreast Cancer Research and Treatment, 2012
- Age-Specific Nonpersistence of Endocrine Therapy in Postmenopausal Patients Diagnosed with Hormone Receptor–Positive Breast Cancer: A TEAM Study AnalysisThe Oncologist, 2011
- Compliance and persistence of endocrine adjuvant breast cancer therapyBreast Cancer Research and Treatment, 2011
- Cigarette Smoking, Obesity, Physical Activity, and Alcohol Use As Predictors of Chemoprevention Adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention TrialCancer Prevention Research, 2011
- Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancerBreast Cancer Research and Treatment, 2011
- Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancerBritish Journal of Cancer, 2011
- Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer PatientsJournal of Clinical Oncology, 2010
- Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancerBritish Journal of Cancer, 2008
- Adherence to tamoxifen over the five-year courseBreast Cancer Research and Treatment, 2006